Stevanato Group to Participate in Upcoming Investor Conferences

Core Insights - Stevanato Group S.p.A. will participate in two upcoming investor conferences, indicating its active engagement with investors and the market [1][9] - The company is a leading global provider of drug containment, drug delivery, and diagnostic solutions, serving the pharmaceutical, biotechnology, and life sciences industries [3][8] Upcoming Events - The company will attend the 7th Annual Wolfe Research Healthcare Conference in New York City on November 17, 2025, at 8:40 a.m. ET [5] - It will also participate in the Jefferies Global Healthcare Conference in London on November 19, 2025, at 11:00 a.m. GMT [5] Company Overview - Founded in 1949, Stevanato Group offers an integrated portfolio of products, processes, and services that address customer needs across the entire drug life cycle [3] - The company's core capabilities include scientific research and development, technical innovation, and engineering excellence, which are essential for providing value-added solutions to clients [3]